Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility

Nature Biotechnology volume 28, pages 801–805 (2010)Cite this article

Subjects

The court narrowly ruled that business methods may be patent eligible, while striking down the primacy of its main test.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Number of amicus briefs from biotech and pharma sector vis-à-vis Bilski v. Kappos.
Figure 2: Amicus briefs from biotech and pharma sector supporting or against Bilski machine-or-transformation test.

References

  1. Langer, E.S. Realistic expectations likely to prevail in 2010. Gen. Eng. News (March 1, 2010).

    Google Scholar 

  2. In re Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc).

  3. Simmons, W.J. Nat. Biotechnol. 27, 245–248 (2009).

    Article  CAS  Google Scholar 

  4. In re Bilski, 545 F.3d at 954.

  5. Diamond v. Diehr, 450 US 175, 185 (1981).

  6. Lab Corp. v. Metabolite (Fed. Cir. 2004).

  7. Gottschalk v. Benson, 409 US 63 (1972).

  8. Parker v. Flook, 437 US 584 (1978).

  9. Bilski v. Kappos, 561 US (2010) at 8.

  10. Association for Molecular Pathology et al. v. USPTO et al. 1:09 cv-04515 (SDNY).

  11. Prometheus Laboratories v. Mayo Collaborative Servs., 581 F.3d 1336 (Fed. Cir. 2009).

  12. 561 US (2010) - Kennedy, p. 9.

  13. 561 US (2010) - Kennedy, pp. 12–13.

  14. Diamond v. Chakrabarty 447 US 303 (1980).

  15. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuNovartisCorp.pdf

  16. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuCarisDiagnostics.pdf

  17. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuGaBio.pdf

  18. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_PetitionerAmCuUnivofSFlorida.pdf

  19. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_PetitionerAmCuAChakrabarty.pdf

  20. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuPrometheusLabs.pdf

  21. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCu2PersonalizedMedOrgs.pdf

  22. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuMedtronic.pdf

  23. http://www.abanet.org/publiced/preview/briefs/pdfs/07-08/08-964_NeutralAmCuPhRMA.pdf

  24. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCuKEI.pdf

  25. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCu2PharmCos.pdf

  26. http://www.abanet.org/publiced/preview/briefs/pdfs/09-10/08-964_RespondentAmCu5MedicalGrps.pdf

Download references

Acknowledgements

The views expressed are solely the author's and do not represent those of Sughrue Mion and its clients, and are subject to changes in the art and law. The author thanks An Kang Li and Stuart Levy for their cotributions.

Author information

Authors and Affiliations

  1. William J. Simmons is at Sughrue Mion, PLLC, Washington, DC, USA.,

    William J Simmons

Authors
  1. William J Simmons
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William J Simmons.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simmons, W. Bilski v. Kappos: the US Supreme Court broadens patent subject-matter eligibility. Nat Biotechnol 28, 801–805 (2010). https://doi.org/10.1038/nbt0810-801

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0810-801

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research